{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:16:17Z","timestamp":1794028577729,"version":"4.8.0"},"reference-count":201,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Brain metastasis is the most commonly seen brain malignancy, frequently originating from lung cancer, breast cancer, and melanoma. Brain tumor has its unique cell types, anatomical structures, metabolic constraints, and immune environment, which namely the tumor microenvironment (TME). It has been discovered that the tumor microenvironment can regulate the progression, metastasis of primary tumors, and response to the treatment through the particular cellular and non-cellular components. Brain metastasis tumor cells that penetrate the brain\u2013blood barrier and blood\u2013cerebrospinal fluid barrier to alter the function of cell junctions would lead to different tumor microenvironments. Emerging evidence implies that these tumor microenvironment components would be involved in mechanisms of immune activation, tumor hypoxia, antiangiogenesis, etc. Researchers have applied various therapeutic strategies to inhibit brain metastasis, such as the combination of brain radiotherapy, immune checkpoint inhibitors, and monoclonal antibodies. Unfortunately, they hardly access effective treatment. Meanwhile, most clinical trials of target therapy patients with brain metastasis are always excluded. In this review, we summarized the clinical treatment of brain metastasis in recent years, as well as their influence and mechanisms underlying the differences between the composition of tumor microenvironments in the primary tumor and brain metastasis. We also look forward into the feasibility and superiority of tumor microenvironment-targeted therapies in the future, which may help to improve the strategy of brain metastasis treatment.<\/jats:p>","DOI":"10.3389\/fcell.2021.722917","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T09:24:54Z","timestamp":1629797094000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Blood\u2013Brain Barrier, Cell Junctions, and Tumor Microenvironment in Brain Metastases, the Biological Prospects and Dilemma in Therapies"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhiyuan","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases.","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0184","article-title":"HER2-specific chimeric antigen receptor\u2013modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial.","volume":"3","author":"Ahmed","year":"2017","journal-title":"JAMA Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.molimm.2018.06.267","article-title":"Blood-brain barrier (BBB) and the complement landscape.","volume":"102","author":"Alexander","year":"2018","journal-title":"Mol. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From krebs to clinic: glutamine metabolism to cancer therapy.","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1200\/JCO.2010.30.8213","article-title":"Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study.","volume":"29","author":"Andersson","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma.","volume":"33","author":"Andtbacka","year":"2015","journal-title":"JCO"},{"key":"B7","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2018.08.006","article-title":"Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies.","volume":"28","author":"Apicella","year":"2018","journal-title":"Cell Metab."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment.","volume":"56","author":"Arneth","year":"2019","journal-title":"Medicina"},{"key":"B9","first-page":"4028","article-title":"Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis.","volume":"5","author":"Arnold","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/path.4304","article-title":"Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain.","volume":"232","author":"Avraham","year":"2014","journal-title":"J. Pathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood-2009-06-227934","article-title":"CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells.","volume":"115","author":"Baessler","year":"2010","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance.","volume":"125","author":"Balkwill","year":"2012","journal-title":"J. Cell. Sci."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153088","article-title":"4-1BB signaling in conventional T cells drives IL-2 production that overcomes CD4+CD25+FoxP3+ T regulatory cell suppression.","volume":"11","author":"Barsoumian","year":"2016","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1158\/0008-5472.CAN-04-3332","article-title":"Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.","volume":"65","author":"Beppu","year":"2005","journal-title":"Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1057388","article-title":"Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases.","volume":"5","author":"Berghoff","year":"2016","journal-title":"Oncoimmunology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10585-012-9510-4","article-title":"Characterization of the inflammatory response to solid cancer metastases in the human brain.","volume":"30","author":"Berghoff","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2217\/cns.14.51","article-title":"Brain metastases: an overview.","volume":"4","author":"Bertolini","year":"2015","journal-title":"CNS Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1158\/1078-0432.CCR-14-2082","article-title":"Bevacizumab in patients with nonsquamous non-small cell lung cancer and asymptomatic, untreated brain metastases (BRAIN): a nonrandomized, phase II study.","volume":"21","author":"Besse","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth.","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2217\/fon-2017-0255","article-title":"Medical management of brain metastases and leptomeningeal disease in patients with breast carcinoma.","volume":"14","author":"Bowman","year":"2018","journal-title":"Future Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets.","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment.","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and Warburg phenomenon.","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/eji.201141920","article-title":"4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia.","volume":"42","author":"Buechele","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism.","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases.","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1158\/0008-5472.CAN-14-2268","article-title":"Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain.","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature18268","article-title":"Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer.","volume":"533","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10555-007-9083-x","article-title":"Breast cancer brain metastases.","volume":"26","author":"Cheng","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1172\/JCI83092","article-title":"Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.","volume":"126","author":"Cherkassky","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1200\/JCO.2017.73.7379","article-title":"Randomized, open-label phase II Study evaluating the efficacy and safety of talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone in patients with advanced, unresectable melanoma.","volume":"36","author":"Chesney","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1182\/blood-2017-06-741041","article-title":"Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies.","volume":"131","author":"Chester","year":"2018","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2222.2006.02445.x","article-title":"4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.","volume":"36","author":"Cho","year":"2006","journal-title":"Clin. Exp. Allergy"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav5989","article-title":"Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy.","volume":"11","author":"Claus","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ni.2705","article-title":"Tissue-resident macrophages.","volume":"14","author":"Davies","year":"2013","journal-title":"Nat. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJMcibr1914890","article-title":"Tumor microenvironment, metabolism, and immunotherapy.","volume":"382","author":"DeBerardinis","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrm1357","article-title":"Endothelial cell-cell junctions: happy together.","volume":"5","author":"Dejana","year":"2004","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-319-78127-3_6","article-title":"Stromal cells in the tumor microenvironment.","volume":"1060","author":"Denton","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc2397","article-title":"Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response.","volume":"8","author":"Dewhirst","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics.","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B43","doi-asserted-by":"publisher","first-page":"E6157","DOI":"10.1073\/pnas.1700363114","article-title":"Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.","volume":"114","author":"Du","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.50","article-title":"Hypoxia and metabolic adaptation of cancer cells.","volume":"5","author":"Eales","year":"2016","journal-title":"Oncogenesis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.trecan.2020.04.007","article-title":"Genes that mediate metastasis across the blood-brain barrier.","volume":"6","author":"Fares","year":"2020","journal-title":"Trends Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020599","article-title":"Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.","volume":"6","author":"Feng","year":"2011","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/805629","article-title":"Systemic delivery of oncolytic viruses: hopes and hurdles.","volume":"2012","author":"Ferguson","year":"2012","journal-title":"Adv. Virol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10585-008-9193-z","article-title":"Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization.","volume":"25","author":"Fitzgerald","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2008.11.008","article-title":"Mitochondria in cancer: not just innocent bystanders.","volume":"19","author":"Frezza","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10571-019-00725-0","article-title":"Pericytes suppress brain metastasis from lung cancer in vitro.","volume":"40","author":"Fujimoto","year":"2020","journal-title":"Cell Mol. Neurobiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00432-014-1583-9","article-title":"Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.","volume":"140","author":"Garon","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imr.12224","article-title":"Tissue macrophage identity and self-renewal.","volume":"262","author":"Gentek","year":"2014","journal-title":"Immunol. Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J. Exp. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrn2757","article-title":"Astroglial networks: a step further in neuroglial and gliovascular interactions.","volume":"11","author":"Giaume","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"24S","DOI":"10.2967\/jnumed.107.047258","article-title":"Causes and consequences of increased glucose metabolism of cancers.","volume":"49","author":"Gillies","year":"2008","journal-title":"J. Nucl. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrc3298","article-title":"Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.","volume":"12","author":"Gillies","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137057","article-title":"Behind brain metastases formation: cellular and molecular alterations and blood-brain barrier disruption.","volume":"22","author":"Godinho-Pereira","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/CJI.0000000000000260","article-title":"Pilot trial of adoptive transfer of chimeric antigen receptor\u2013transduced T cells targeting EGFRvIII in patients with glioblastoma.","volume":"42","author":"Goff","year":"2019","journal-title":"J. Immunother."},{"key":"B59","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","article-title":"Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.","volume":"17","author":"Goldberg","year":"2016","journal-title":"Lancet Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/379088a0","article-title":"Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.","volume":"379","author":"Graeber","year":"1996","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0714-8","article-title":"EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET\/CT scan.","volume":"33","author":"Guan","year":"2016","journal-title":"Med. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1158\/1078-0432.CCR-17-0432","article-title":"Phase I study of chimeric antigen receptor-modified T cells in patients with EGFR-positive advanced biliary tract cancers.","volume":"24","author":"Guo","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18115-2","article-title":"Circadian control of brain glymphatic and lymphatic fluid flow.","volume":"11","author":"Hablitz","year":"2020","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment.","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1786","article-title":"Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels.","volume":"3","author":"Harada","year":"2012","journal-title":"Nat. Commun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri1589","article-title":"Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma.","volume":"5","author":"Hawrylowicz","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2119\/2006-00033.he","article-title":"Differential reactions of microglia to brain metastasis of lung cancer.","volume":"12","author":"He","year":"2006","journal-title":"Mol. Med."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131246","article-title":"Tandem CAR T cells targeting HER2 and IL13R\u03b12 mitigate tumor antigen escape.","volume":"129","author":"Hegde","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","article-title":"Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC.","volume":"383","author":"Herbst","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/cr.2013.15","article-title":"A proposed role for glutamine in cancer cell growth through acid resistance.","volume":"23","author":"Huang","year":"2013","journal-title":"Cell Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-14-3587","article-title":"Perivascular M2 macrophages stimulate tumor relapse after chemotherapy.","volume":"75","author":"Hughes","year":"2015","journal-title":"Cancer Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells.","volume":"191","author":"Husain","year":"2013","journal-title":"J. Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/11320","article-title":"Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses.","volume":"5","author":"Ikeda","year":"1999","journal-title":"Nat. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S1474-4422(15)00221-5","article-title":"Implications of the discovery of brain lymphatic pathways.","volume":"14","author":"Iliff","year":"2015","journal-title":"Lancet Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","article-title":"Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery.","volume":"565","author":"Ito","year":"2019","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1215\/15228517-2008-104","article-title":"Regulatory T cells and the PD-L1\/PD-1 pathway mediate immune suppression in malignant human brain tumors.","volume":"11","author":"Jacobs","year":"2009","journal-title":"Neuro. Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3892\/mmr.2013.1875","article-title":"The role of claudin-5 in blood-brain barrier (BBB) and brain metastases (review).","volume":"9","author":"Jia","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"6801","DOI":"10.1158\/1078-0432.CCR-19-0405","article-title":"Localized treatment with oncolytic adenovirus delta-24-RGDOX induces systemic immunity against disseminated subcutaneous and intracranial melanomas.","volume":"25","author":"Jiang","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0360-3016(00)01532-7","article-title":"A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics.","volume":"49","author":"Kavanagh","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020185","article-title":"Involvement of CXCR4 in normal and abnormal development.","volume":"8","author":"Kawaguchi","year":"2019","journal-title":"Cells"},{"key":"B81","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity.","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5214-8","article-title":"Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors.","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/ijc.32531","article-title":"A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.","volume":"145","author":"Kim","year":"2019","journal-title":"Int. J. Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1158\/1078-0432.CCR-14-3073","article-title":"Characterization of PD-L1 expression and associated T-cell infiltrates in metastatic melanoma samples from variable anatomic sites.","volume":"21","author":"Kluger","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2016.01.021","article-title":"TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis.","volume":"89","author":"Korneev","year":"2017","journal-title":"Cytokine"},{"key":"B87","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41551-018-0254-6","article-title":"A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer.","volume":"2","author":"Kulkarni","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"B88","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.semcancer.2019.10.010","article-title":"Brain malignancies: glioblastoma and brain metastases.","volume":"60","author":"Lah","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1158\/0008-5472.CAN-20-1829","article-title":"Junctional adhesion molecules in cancer: a paradigm for the diverse functions of cell-cell interactions in tumor progression.","volume":"80","author":"Lauko","year":"2020","journal-title":"Cancer Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/1541-7786.MCR-18-0630","article-title":"c-MYC drives breast cancer metastasis to the brain, but promotes synthetic lethality with TRAIL.","volume":"17","author":"Lee","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0235-1","article-title":"Hypoxia signaling in human diseases and therapeutic targets.","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ceb.2012.01.005","article-title":"From stem cells to cancer stem cells: HIF takes the stage.","volume":"24","author":"Lee","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/onc.2014.47","article-title":"PCK2 activation mediates an adaptive response to glucose depletion in lung cancer.","volume":"34","author":"Leithner","year":"2015","journal-title":"Oncogene"},{"key":"B94","first-page":"5259","article-title":"AMD3100 inhibits brain-specific metastasis in lung cancer via suppressing the SDF-1\/CXCR4 axis and protecting blood-brain barrier.","volume":"9","author":"Li","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pharmthera.2017.08.012","article-title":"Bevacizumab-induced hypertension: clinical presentation and molecular understanding.","volume":"182","author":"Li","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1200\/JCO.2004.01.175","article-title":"CNS metastases in breast cancer.","volume":"22","author":"Lin","year":"2004","journal-title":"JCO"},{"key":"B97","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1172\/JCI123027","article-title":"Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2\u03b1-mediated tumor progression.","volume":"129","author":"Liu","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B98","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jcyt.2020.04.088","article-title":"Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: a phase I clinical trial.","volume":"22","author":"Liu","year":"2020","journal-title":"Cytotherapy"},{"key":"B99","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.2353\/ajpath.2010.090838","article-title":"Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.","volume":"176","author":"Lorger","year":"2010","journal-title":"Am. J. Pathol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1038\/onc.2012.417","article-title":"Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis.","volume":"32","author":"Louie","year":"2013","journal-title":"Oncogene"},{"key":"B102","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels.","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbcan.2016.12.001","article-title":"Brain metastasis: unique challenges and open opportunities.","volume":"1867","author":"Lowery","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-12734-3_1","article-title":"Hypoxia mediates tumor malignancy and therapy resistance","author":"Luo","year":"2019","journal-title":"Hypoxia and Cancer Metastasis, Advances in Experimental Medicine and Biology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/annonc\/mdw289","article-title":"Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer.","volume":"27","author":"Mansfield","year":"2016","journal-title":"Ann. Oncol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology.","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells.","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/omi.12129","article-title":"Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.","volume":"31","author":"Mastellos","year":"2016","journal-title":"Mol. Oral. Microbiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10585-005-8115-6","article-title":"Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.","volume":"22","author":"Mendes","year":"2005","journal-title":"Clin. Exp. Metastasis"},{"key":"B111","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","article-title":"Sugar for the brain: the role of glucose in physiological and pathological brain function.","volume":"36","author":"Mergenthaler","year":"2013","journal-title":"Trends Neurosci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","article-title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br. J. Cancer"},{"key":"B113","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.4161\/cc.8.20.9741","article-title":"Hypoxia, angiogenesis and cancer therapy: to breathe or not to breathe?","volume":"8","author":"Michieli","year":"2009","journal-title":"Cell Cycle"},{"key":"B114","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J. Exp. Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1158\/1078-0432.CCR-13-2627","article-title":"Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors.","volume":"20","author":"Moon","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","article-title":"Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer.","volume":"17","author":"Mu","year":"2018","journal-title":"Cell Cycle"},{"key":"B117","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis.","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s10753-014-0082-0","article-title":"Natural killer cell functional activity after 4-1BB costimulation.","volume":"38","author":"Navabi","year":"2015","journal-title":"Inflammation"},{"key":"B119","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/B978-0-12-811161-1.00006-2","article-title":"Brain metastasis: clinical manifestations, symptom management, and palliative care.","volume":"149","author":"Noh","year":"2018","journal-title":"Handb Clin. Neurol."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.","volume":"9","author":"O\u2019Rourke","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-811161-1.00002-5","article-title":"Brain metastases: epidemiology.","volume":"149","author":"Ostrom","year":"2018","journal-title":"Handb Clin. Neurol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.celrep.2016.03.026","article-title":"ERR\u03b1-regulated lactate metabolism contributes to resistance to targeted therapies in breast cancer.","volume":"15","author":"Park","year":"2016","journal-title":"Cell Rep."},{"key":"B123","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/bjc.1992.17","article-title":"Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.","volume":"65","author":"Parliament","year":"1992","journal-title":"Br. J. Cancer"},{"key":"B124","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism.","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metabolism"},{"key":"B125","doi-asserted-by":"publisher","first-page":"745","DOI":"10.21037\/tlcr-20-500","article-title":"The effect of combining endostar with radiotherapy on blood vessels, tumor-associated macrophages, and T cells in brain metastases of Lewis lung cancer.","volume":"9","author":"Peng","year":"2020","journal-title":"Transl. Lung. Cancer Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1200\/JCO.2016.71.9476","article-title":"Phase II trial of atezolizumab as first-line or subsequent therapy for patients with programmed death-ligand 1-selected advanced non-small-cell lung cancer (BIRCH).","volume":"35","author":"Peters","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1164\/rccm.200301-071OC","article-title":"The stromal derived factor-1\/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.","volume":"167","author":"Phillips","year":"2003","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B129","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.imlet.2016.06.006","article-title":"CXCR4 signaling in health and disease.","volume":"177","author":"Pozzobon","year":"2016","journal-title":"Immunol. Lett."},{"key":"B130","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1158\/1078-0432.CCR-17-2041","article-title":"Regional delivery of chimeric antigen receptor-engineered T cells effectively targets HER2+ breast cancer metastasis to the brain.","volume":"24","author":"Priceman","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41591-018-0044-4","article-title":"STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis.","volume":"24","author":"Priego","year":"2018","journal-title":"Nat. Med."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00043","article-title":"Melanoma unknown primary brain metastasis treatment with ECHO-7 oncolytic virus rigvir: a case report.","volume":"8","author":"Proboka","year":"2018","journal-title":"Front. Oncol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1002\/cncr.30138","article-title":"Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.","volume":"122","author":"Qian","year":"2016","journal-title":"Cancer"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0992-4","article-title":"Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment.","volume":"18","author":"Qu","year":"2019","journal-title":"Mol. Cancer"},{"key":"B135","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors.","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"B136","doi-asserted-by":"publisher","first-page":"10237","DOI":"10.1073\/pnas.172399499","article-title":"Appraising the brain\u2019s energy budget.","volume":"99","author":"Raichle","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B137","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature09615","article-title":"The myeloid cells of the central nervous system parenchyma.","volume":"468","author":"Ransohoff","year":"2010","journal-title":"Nature"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1158\/1535-7163.MCT-09-0274","article-title":"Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.","volume":"8","author":"Rapisarda","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"B139","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ceb.2017.05.006","article-title":"Metabolism shapes the tumor microenvironment.","volume":"48","author":"Reina-Campos","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/s0021-9258(17)30124-2","article-title":"Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.","volume":"254","author":"Reitzer","year":"1979","journal-title":"J. Biol. Chem."},{"key":"B141","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ctrv.2011.02.002","article-title":"Novel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathway.","volume":"37","author":"Ribatti","year":"2011","journal-title":"Cancer Treat. Rev."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00018.2019","article-title":"Immunity, hypoxia, and metabolism-the m\u00e9nage \u00e0 trois of cancer: implications for immunotherapy.","volume":"100","author":"Riera-Domingo","year":"2020","journal-title":"Physiol. Rev."},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040840","article-title":"Targeting tumor microenvironment for cancer therapy.","volume":"20","author":"Roma-Rodrigues","year":"2019","journal-title":"IJMS"},{"key":"B144","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy.","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.smim.2008.04.001","article-title":"Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.","volume":"20","author":"Sampson","year":"2008","journal-title":"Semin. Immunol."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01713","article-title":"Microenvironmental regulation of tumor progression and therapeutic response in brain metastasis.","volume":"10","author":"Schulz","year":"2019","journal-title":"Front. Immunol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1289\/ehp.0901334","article-title":"Polychlorinated biphenyls disrupt blood-brain barrier integrity and promote brain metastasis formation.","volume":"118","author":"Seelbach","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"B148","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10585-010-9354-8","article-title":"Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis.","volume":"28","author":"Seike","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2015.01.002","article-title":"Anatomy and physiology of the blood\u2013brain barrier.","volume":"38","author":"Serlin","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1200\/JCO.2003.08.116","article-title":"RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the radiation therapy oncology group recursive partitioning analysis brain metastases database.","volume":"21","author":"Shaw","year":"2003","journal-title":"JCO"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/sj.jcbfm.9600521","article-title":"Supply and demand in cerebral energy metabolism: the role of nutrient transporters.","volume":"27","author":"Simpson","year":"2007","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"B152","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cytogfr.2008.04.003","article-title":"Immune regulation and control of regulatory T cells by OX40 and 4-1BB.","volume":"19","author":"So","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"B153","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology.","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41586-019-1912-x","article-title":"VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours.","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx071","article-title":"Therapeutic targeting of the pyruvate dehydrogenase complex\/pyruvate dehydrogenase kinase (PDC\/PDK) axis in cancer.","volume":"109","author":"Stacpoole","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2016.1154641","article-title":"Junctional proteins of the blood-brain barrier: new insights into function and dysfunction.","volume":"4","author":"Stamatovic","year":"2016","journal-title":"Tissue Barriers"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100057","article-title":"Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases.","volume":"6","author":"Steindl","year":"2021","journal-title":"ESMO Open"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-283","article-title":"Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.","volume":"12","author":"Steinmann","year":"2012","journal-title":"BMC Cancer"},{"key":"B160","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1517\/13543784.13.5.543","article-title":"Efaproxiral: a novel radiation sensitiser.","volume":"13","author":"Suh","year":"2004","journal-title":"Exp. Opin Invest. Drugs"},{"key":"B161","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2004.00.1768","article-title":"Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.","volume":"24","author":"Suh","year":"2006","journal-title":"JCO"},{"key":"B162","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1158\/1078-0432.CCR-18-1211","article-title":"Preventing Lck activation in CAR T cells confers treg resistance but requires 4-1BB Signaling for Them to persist and treat solid tumors in nonlymphodepleted hosts.","volume":"25","author":"Suryadevara","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1470-2045(13)70130-X","article-title":"Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.","volume":"14","author":"Swain","year":"2013","journal-title":"Lancet Oncol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"E1540","DOI":"10.1073\/pnas.1714089115","article-title":"Anti-PD-1\/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking.","volume":"115","author":"Taggart","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B165","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","article-title":"The expression and distribution of the hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 in normal human tissues, cancers, and tumor-associated macrophages.","volume":"157","author":"Talks","year":"2000","journal-title":"Am. J. Pathol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1039\/c8cs00805a","article-title":"Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"B167","first-page":"4373","article-title":"Acid pH in tumors and its potential for therapeutic exploitation.","volume":"49","author":"Tannock","year":"1989","journal-title":"Cancer Res."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/ncb3272","article-title":"Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.","volume":"17","author":"Tardito","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.","volume":"4","author":"Taube","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrc2817","article-title":"Targeting metabolic transformation for cancer therapy.","volume":"10","author":"Tennant","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246140","article-title":"Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes.","volume":"20","author":"Tirpe","year":"2019","journal-title":"IJMS"},{"key":"B172","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","article-title":"Brain tumor microenvironment and host state: implications for immunotherapy.","volume":"25","author":"Tomaszewski","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jnci\/djm135","article-title":"Drug resistance and the solid tumor microenvironment.","volume":"99","author":"Tr\u00e9dan","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"B174","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ctrv.2017.02.004","article-title":"Management of brain metastasized non-small cell lung cancer (NSCLC)from local treatment to new systemic therapies.","volume":"54","author":"Tsakonas","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"B175","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/jnr.20586","article-title":"Inhibition of lipopolysaccharide-induced microglial activation by preexposure to neurotrophin-3.","volume":"81","author":"Tzeng","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The blood-brain barrier in systemic inflammation.","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"B177","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1093\/annonc\/mdw316","article-title":"Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent\/metastatic breast cancer.","volume":"27","author":"Vrdoljak","year":"2016","journal-title":"Ann. Oncol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review.","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105010","article-title":"CXCR4 antagonist AMD3100 (plerixafor): from an impurity to a therapeutic agent.","volume":"159","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218363","article-title":"Lactic acid and an acidic tumor microenvironment suppress anticancer immunity.","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B181","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1172\/JCI91553","article-title":"JAK2-binding long noncoding RNA promotes breast cancer brain metastasis.","volume":"127","author":"Wang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B182","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells.","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/285246","article-title":"The controversial role of microglia in malignant gliomas.","volume":"2013","author":"Wei","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF00284370","article-title":"The warburg hypothesis fifty years later.","volume":"87","author":"Weinhouse","year":"1976","journal-title":"Z Krebsforsch Klin Onkol Cancer Res. Clin. Oncol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/MOH.0b013e3282f97d86","article-title":"Vascular permeability in cardiovascular disease and cancer.","volume":"15","author":"Weis","year":"2008","journal-title":"Curr. Opin. Hematol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1152\/physrev.00037.2018","article-title":"Passing the vascular barrier: endothelial signaling processes controlling extravasation.","volume":"99","author":"Wettschureck","year":"2019","journal-title":"Physiol. Rev."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.celrep.2019.03.085","article-title":"Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis.","volume":"27","author":"Wingrove","year":"2019","journal-title":"Cell Rep."},{"key":"B188","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1021\/jm00106a042","article-title":"Allosteric modifiers of hemoglobin. 2. crystallographically determined binding sites and hydrophobic binding\/interaction analysis of novel hemoglobin oxygen effectors.","volume":"34","author":"Wireko","year":"1991","journal-title":"J. Med. Chem."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/1535-7163.MCT-19-0079","article-title":"Metabolic flexibility in cancer: targeting the pyruvate dehydrogenase kinase:pyruvate dehydrogenase axis.","volume":"18","author":"Woolbright","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"B190","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response.","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"key":"B191","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.7150\/thno.42234","article-title":"BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFRT790M mutation.","volume":"10","author":"Yin","year":"2020","journal-title":"Theranostics"},{"key":"B192","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature15376","article-title":"Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.","volume":"527","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"B193","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1158\/1078-0432.CCR-18-2548","article-title":"A novel mTORC1\/2 Inhibitor (MTI-31) inhibits tumor growth, epithelial-mesenchymal transition, metastases, and improves antitumor immunity in preclinical models of lung cancer.","volume":"25","author":"Zhang","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.drudis.2015.03.012","article-title":"Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents.","volume":"20","author":"Zhang","year":"2015","journal-title":"Drug Discov. Today"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jconrel.2020.10.052","article-title":"Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity.","volume":"329","author":"Zhao","year":"2021","journal-title":"J. Control Release"},{"key":"B196","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1177\/0271678X20911331","article-title":"Multifaceted roles of pericytes in central nervous system homeostasis and disease.","volume":"40","author":"Zheng","year":"2020","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"B197","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.bbrc.2018.03.053","article-title":"Programmed death ligand 1 expression and CD8+ tumor-infiltrating lymphocyte density differences between paired primary and brain metastatic lesions in non-small cell lung cancer.","volume":"498","author":"Zhou","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B198","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1021\/acsami.9b18633","article-title":"Overcoming radioresistance in tumor therapy by alleviating hypoxia and using the HIF-1 inhibitor.","volume":"12","author":"Zhou","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B199","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","article-title":"Mitochondria and cancer.","volume":"61","author":"Zong","year":"2016","journal-title":"Mol. Cell"},{"key":"B200","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy.","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1158\/2159-8290.CD-19-0270","article-title":"Polyunsaturated fatty acids from astrocytes activate PPAR\u03b3 signaling in cancer cells to promote brain metastasis.","volume":"9","author":"Zou","year":"2019","journal-title":"Cancer Discov"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.722917\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T09:25:01Z","timestamp":1629797101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.722917\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":201,"alternative-id":["10.3389\/fcell.2021.722917"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.722917","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"article-number":"722917"}}